From the various reports, it has been shown that ERRα, but not ERRβ or ERRγ, is upregulated in NSCLC, which can induce proliferation and migration of cancer cells, and inhibiting ERRα may be a promising strategy for lung cancer therapy. Here, ESRRA is linked to non-small cell lung carcinoma.